Drug Policy Alliance
Drug Policy Alliance (DPA) is a non-profit organization based in New York City, United States. It is committed to promoting drug policies that are grounded in science, compassion, health, and human rights. The organization is actively involved in the legislative process and aims to roll back the excessive laws of the war on drugs, particularly those that are disproportionately affecting certain communities.
History[edit]
The Drug Policy Alliance was established in 2000 by merging two organizations: the Lindesmith Center and the Drug Policy Foundation. The Lindesmith Center was founded by Ethan Nadelmann in 1994, while the Drug Policy Foundation was established in 1987. The merger was aimed at creating a unified voice for drug policy reform.
Mission and Goals[edit]
The DPA's mission is to advance policies and attitudes that best reduce the harms of both drug use and drug prohibition. It envisions a just society in which the use and regulation of drugs are grounded in science, compassion, health, and human rights. The organization's goals include:
- Ending the war on drugs
- Promoting harm reduction interventions
- Advocating for responsible drug use
- Supporting alternatives to incarceration for drug offenses
Activities[edit]
The DPA is involved in a wide range of activities, including policy advocacy, public education, and litigation. It has played a pivotal role in the passage of many drug reform laws at the state and federal levels. The organization also provides resources and support to individuals and communities affected by the war on drugs.
Criticism and Controversy[edit]
While the DPA's work has been praised by many, it has also faced criticism. Some critics argue that the organization's approach to drug policy reform is too lenient and could lead to increased drug use and related harms. However, the DPA maintains that its policies are based on scientific evidence and are designed to reduce harm rather than promote drug use.
See Also[edit]
References[edit]
<references />
 | This medical article is a stub. You can help Wikipedia by adding missing information. |
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
